Both in Pharmaceuticals
Emergent Biosolutions vs Arcturus Therapeutics Holdings
Over the past year EBS returned −25.1% and ARCT returned +22.2%; their daily moves had a correlation of 0.32.
EBS −25.1% ARCT +22.2%Growth of $1, one year, split-adjusted
| Metric | EBS | ARCT |
|---|---|---|
| Price | $7.09 | $12.07 |
| Market cap | $363.5M | $343.1M |
| Today | +6.30% | +7.48% |
| 1 month | +2.5% | −11.9% |
| 6 months | −11.3% | +43.7% |
| Year to date | −42.6% | +96.9% |
| 1 year | −26.8% | +14.0% |
| Revenue growth (YoY) | +66.3% | −89.5% |
| Gross margin | 58.6% | 100.0% |
| Net margin | −76.9% | −803.8% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 11.7× |
| Net cash | -$442.1M | $191.5M |
| Dividend yield | — | — |
| Volatility (60d) | 97.9% | 113.0% |
| Short % of float | 19.3% | 19.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).